1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
AK Medical Holdings Limited

AK Medical Holdings Limited

1789.HK
AK Medical Holdings LimitedHK flagHong Kong Stock Exchange
5.25
HKD
-0.04
- -
5.62BMarket Cap
AK Medical Holdings Limited
1789.HK
(Hong Kong Stock Exchange)

Recent

price

5.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.15
0.21
0.27
0.49
0.58
0.89
0.94
0.68
0.95
0.98
1.21
1.33
Revenue per Share
0.05
0.06
0.08
0.14
0.14
0.26
0.28
0.08
0.18
0.16
0.25
0.3
Basic EPS, GAAP
0.04
0.01
0.04
0.09
0.05
0.04
0.1
0.09
0.11
-0.15
0.26
0.24
Free Cash Flow per Basic Share
0.03
0.1
0.05
0.1
0.03
0.03
0.07
0.03
0.02
0.06
0.04
0.07
Dividend per Share
0.12
0.08
0.13
0.26
0.33
0.59
0.84
0.91
1.1
1.26
1.46
1.7
Book Value per Share
0.15
0.17
0.29
0.87
0.75
0.99
1.64
1.62
1.78
1.91
2.13
2.38
Tangible Book Value per Share
1,000
1,000
1,000
758
1,037
1,042
1,102
1,113
1,109
1,113
1,116
1,117
Basic Weighted Avg Shares
148
206
271
373
601
927
1,035
761
1,052
1,094
1,346
1,482
Sales/Revenue/Turnover
38.97
35.39
34.48
33.51
28.51
32.66
36.49
13.06
22.66
19.33
22.34
25.22
Operating Margin (%)
5
5
9
12
21
32
61
74
80
91
96
107
Depreciation Expense
52
65
77
105
145
267
314
93
205
182
274
339
Net Income, GAAP
14.22
14.54
18.63
15.96
16.94
16.93
16.62
14.68
14.78
21.21
14.35
14.15
Effective Tax Rate (%)
34.88
31.48
28.56
28.27
24.13
28.81
30.33
12.16
19.46
16.65
20.35
22.87
Profit Margin (%)
126
123
223
552
597
790
1,485
1,445
1,629
1,477
1,582
2,042
Working Capital
- -
- -
- -
- -
- -
6
15
31
25
49
27
9
LT Debt
156
177
294
668
842
1,116
2,043
2,032
2,244
2,392
2,638
2,913
Total Equity
- -
36.77
30.81
20.88
18.17
24.45
19
3.98
9.16
7.01
9.99
11.36
Return on Invested Capital (%)
- -
65.37
75.36
64.88
53.17
55.28
40.02
9.35
17.81
13.32
17.06
18.38
Return on Capital (%)
- -
65.37
75.36
64.88
53.25
55.91
40.89
9.53
18.28
13.86
18.04
19.21
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
37.21%
7.44%
10.41%
Free Cash Flow
13.31%
-102.07%
-5.92%
Net Income, GAAP
30.85%
22.75%
23.79%
Sales/Revenue/Turnover
24.5%
9.77%
10.11%
Total Cash Common Dividend
18.1%
21.07%
59.71%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,094
2024
- -
- -
- -
- -
1,346
2025
- -
- -
- -
- -
1,482

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.16
2024
- -
- -
- -
- -
0.25
2025
- -
- -
- -
- -
0.3

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.06
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.07
Similar Companies
ViroGates A/S (VIRO.CO)
Eurobio Scientific S.A. (ALERS.PA)
EKF Diagnostics Holdings plc (EKF.L)
Antibe Therapeutics Inc. (ATBPF)
Siemens Healthineers AG (SMMNY)
Olympus Corporation (OCPNY)
Business
AK Medical Holdings Limited functions as an investment holding company, driving the design, development, manufacturing, and global commercialization of orthopedic joint implants and associated medical products. The company features a robust portfolio of offerings, including hip, knee, spine, and trauma replacement implants. A significant area of innovation lies in its advanced 3D-printed products, which encompass bespoke hip and knee implants, artificial vertebral bodies, and spinal interbody cages. Furthermore, AK Medical distributes a range of third-party orthopedic solutions and produces essential surgical instruments and medical irrigators. Recognized as a pioneer in the orthopedic sector, the company was the first globally to apply additive manufacturing (3D printing) technology to joint replacement, spine care, and trauma implants. Its solutions are supplied to a broad base of distributors, hospitals, medical professionals, and patients across China and international markets, supported by manufacturing facilities in both China and the United Kingdom. AK Medical, established in Beijing, People's Republic of China, in 2003, continues to expand its footprint and influence in the global healthcare industry.